A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries-Reference-Cited by-同舟云学术

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

Published:2014-02-19 Issue:3 Volume:37 Page:127-134
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Babigumira Joseph B.,Stergachis Andy,Choi Hye Lyn,Dodoo Alexander,Nwokike Jude,Garrison Louis P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-014-0143-1.pdf

Reference23 articles.

1. The Importance of Pharmacovigilance: World Health Organization. Geneva; 2002.

2. The safety of medicines in public health programmes: pharmacovigilance an essential tool. World Health Organization; 2006. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf .

3. Edwards IR, Isah A. Pharmacovigilance and the null hypothesis: do we do much for public health? Drug Saf. 2011;34(2):93–6.

4. Pietrek M, Coulson R, Czarnecki A. Good pharmacovigilance practice: the way forward? Drug Inf J. 2009;43(5):623–32.

5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs);Drug Safety;2023-10-24

2. The futility of adverse drug event reporting systems for monitoring known safety issues: A case study of myocardial infarction with rofecoxib and other drugs;Pharmacoepidemiology and Drug Safety;2023-10-22

3. An Innovation Framework of Medical Organic Cannabis Traceability in Digital Supply Chain;Journal of Open Innovation: Technology, Market, and Complexity;2022-10-31

4. A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators;Therapeutic Innovation & Regulatory Science;2022-06-03

5. Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa;British Journal of Clinical Pharmacology;2022-02-09